SIPORE

Trademark usage description

dietetic pharmaceutical preparations for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes Read More

Classification Information

Class [005]
Dietetic pharmaceutical preparations for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; pharmaceuticals and natural remedies, namely, natural dietary supplements for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; preparations for use in natural dietary supplements for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; chemical preparations for medical purposes for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; dietary and nutritional supplements, namely, dietary supplements for general health and well-being, dietary supplements for promoting weight loss, dietary supplements for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis, Crohn's disease, cardiovascular risk factors, dietary and nutritional supplements for glycemic control, dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; dietary supplements for persons with special dietary requirements, namely for use in the treatment of prediabetes and diabetes and for promoting weight loss; chemical preparations for pharmaceutical purposes for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the treatment and prevention of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; dietetic pharmaceutical preparations in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for use in the prevention and treatment of metabolic disorders, namely, obesity, being overweight, prediabetes, diabetes, glycemic control, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, inflammatory bowel disease, hypertension, dyslipidaemia, cardiovascular disease and for the promotion of the function of a healthy gastrointestinal tract; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury and inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients

Classification kind code

Class [010]
Medical devices, namely, orally administered medical device for delaying digestion for the safe reduction of blood sugar levels, LDL-cholesterol, adipose tissue, excess fat and for weight loss; capsulated medical devices, namely, orally administered medical device for delaying digestion for the safe reduction of blood sugar levels, LDL-cholesterol, adipose tissue, excess fat and for weight loss; medical devices, namely, orally administered medical device for delaying digestion for the safe reduction of blood sugar levels, LDL-cholesterol, adipose tissue, excess fat and for weight loss for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, and for post bariatric surgery patients

Classification kind code

Mark Details

Serial Number

1902138

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 3^rd Nov 2021	Advertised
Submitted for opposition 27 on 5^th Oct 2021	Approval Notice Sent
Submitted for opposition 26 on 5^th Oct 2021	Approved
Submitted for opposition 15 on 15^th Jan 2021	Correspondence Created
Submitted for opposition 22 on 14^th Feb 2020	Search Recorded
Submitted for opposition 20 on 14^th Feb 2020	Examiner's First Report
Submitted for opposition 67 on 11^th Sept 2019	Agent Name Changed
Submitted for opposition 31 on 5^th Jun 2018	Formalized
Submitted for opposition 1 on 4^th Jun 2018	Created
Submitted for opposition 30 on 1^st Jun 2018	Filed